EMPOWER CLINICS INC - EPWCF STOCK NEWS

Empower Clinics updates on its management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing annual financial statements for the year ended December 31, 2021. The company failed to meet the May 2, 2022 deadline and subsequently missed the May 30, 2022 interim filing deadline. Empower received an extension to file the required documents by July 15, 2022. The company will provide bi-weekly updates according to National Policy 12-203, confirming no material changes have occurred since the initial announcement.

Empower Clinics Inc. (OTCQB:EPWCF) updates on its Management Cease Trade Order (MCTO) from the British Columbia Securities Commission issued on May 3, 2022. The MCTO arose due to delays in filing annual financial statements for the year ending December 31, 2021. The company anticipates the audit for these filings will be completed by June 30, 2022, delaying the interim financial statements previously due on May 30, 2022. Empower confirms no material changes affecting its operations have occurred since the last announcement on May 3, 2022.

Empower Clinics Inc. has rebranded its medical diagnostics lab to Medisure Laboratory, aiming to enhance its presence in the U.S. healthcare market. This change promises expanded access to major healthcare centers in Texas and cruise ship industries. The company plans to secure additional FDA certifications for its medical devices and improve quality management systems. Empower asserts that the Medisure brand is poised for growth, targeting various sectors including film and television.

Empower Clinics reported a significant revenue boost following the administration of over 3,000 COVID-19 tests since June 1. This growth stems from their accredited healthcare practice in Vancouver, B.C., catering to travelers and cruise ships. The company expects over 300 cruise ship calls this season, enhancing business prospects. Empower's testing solutions, including in-person and virtual options, are priced from $100 CAD to $250 CAD per test. The expansion reflects the company's strategic investments in the tourism sector and increased healthcare services.

Empower Clinics Inc. (OTCQB:EPWCF) provided an update on its management cease trade order (MCTO) due to a delay in filing annual financial statements for 2021. The MCTO was issued by the British Columbia Securities Commission on May 3, 2022. The Company anticipates completing its audit by June 30, 2022, allowing it to file interim financial statements. Empower confirms there are no material changes in information since the previous announcement and will continue to provide bi-weekly updates as required under National Policy 12-203.

Empower Clinics has reported strong performance in its first month of offering COVID-19 testing solutions in Vancouver, exceeding 3,000 tests with over 750 pending appointments. All services are fully accredited, enhancing credibility and expected cash flow. The Vancouver cruise industry is recovering, with an estimated 300 cruise ship calls expected in 2022, indicating growing demand for testing. Pricing for testing ranges from $100 CAD to $250 CAD. Empower's services are also promoted by Royal Caribbean, enhancing visibility in the cruise travel market.

Empower Clinics Inc (OTCQB:EPWCF) has filed a trademark application with the U.S. Patent and Trademark Office for the MediSure brand, signaling its intent to expand into the U.S. market. According to CEO Steven McAuley, the MediSure brand has significant potential in the medical device sector and at-home testing products. The trademark filing aims to protect the brand and facilitate future product commercialization in the U.S. Empower's leadership expresses confidence in obtaining FDA approvals for their MediSure portfolio.

Empower Clinics has provided an update regarding its management cease trade order (MCTO) issued by the British Columbia Securities Commission due to delays in filing annual financial statements for the fiscal year ending December 31, 2021. The Required Filings were due on May 2, 2022, and the Interim Filings for March 31, 2022, will also miss the May 30, 2022 deadline. The company expects to complete these filings by June 30, 2022. No material changes have occurred since the initial announcement, and the company commits to continuous updates following Alternative Information Guidelines.

Empower Clinics Inc. (CSE: CBDT, OTCQB: EPWCF) announced its accreditation for mobile COVID-19 testing services through the College of Physicians and Surgeons of BC. This accreditation allows Empower to provide high-quality, concierge testing solutions at various locations, enhancing convenience for large groups. The mobile services adhere to the same standards as their existing testing sites. Empower aims to lead in certified COVID-19 testing solutions, reflecting their commitment to quality and integrity for the travel industry.